XML 87 R74.htm IDEA: XBRL DOCUMENT v3.8.0.1
Supplemental Guarantor Information Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Mar. 31, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Condensed Financial Statements, Captions [Line Items]          
Net Cash Provided by (Used in) Operating Activities $ 29,432   $ 47,812 $ 113,982 $ 100,368
Capital expenditures (29,461)   (25,627) (90,922) (71,087)
Payments to Acquire Businesses, Net of Cash Acquired 0 $ 0 (1,427)   (1,427)
Proceeds from the sale of assets 1,083   4,802 16,538 16,104
Purchase of short term investments and equity securities (3,595)   (21) (13,559) (120)
Sales and maturities of short-term investments 403   5,432 11,321 7,077
Payments for (Proceeds from) Other Investing Activities (5,850)   (1,299) (7,457) (4,218)
Payments to Acquire Interest in Subsidiaries and Affiliates 0   0 0 0
CASH USED IN INVESTING ACTIVITIES (37,420)   (18,140) (84,079) (53,671)
Proceeds from Issuance of Unsecured Debt (2,257)   0 242,701 0
Proceeds from Issuance of Common Stock 0   49,513 0 122,584
Proceeds from Convertible Debt       242,701  
Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities (3,344)   (107,868) (195,501) (120,551)
Cash payments on gold production royalty 0   (7,563) 0 (27,155)
Proceeds From Repayment Intercompany Borrowings 0   0 0 0
Proceeds from (Payments for) Other Financing Activities (6)   1,051 (3,726) 323
Net Cash Provided by (Used in) Financing Activities (5,607)   (64,867) 43,474 (24,799)
Effect of exchange rate changes on cash and cash equivalents (222)   121 662 (95)
Cash and Cash Equivalents, Period Increase (Decrease) (13,817)   (35,074) 74,039 21,803
Cash and cash equivalents at beginning of period 250,038 162,182 257,591 162,182 200,714
Cash and cash equivalents at end of period 236,221   222,517 236,221 222,517
Parent Company [Member]          
Condensed Financial Statements, Captions [Line Items]          
Net Cash Provided by (Used in) Operating Activities (8,682)   101,581 (18,502) 98,323
Capital expenditures (318)   (62) (1,626) (196)
Payments to Acquire Businesses, Net of Cash Acquired     0   0
Proceeds from the sale of assets 0   2 8,917 2
Purchase of short term investments and equity securities (3,594)   (5) (13,558) (104)
Sales and maturities of short-term investments 0   2 9,157 501
Payments for (Proceeds from) Other Investing Activities (5,783)   (1,245) (7,269) (4,383)
Payments to Acquire Interest in Subsidiaries and Affiliates 3,433   (117,911) (9,571) (138,843)
CASH USED IN INVESTING ACTIVITIES (6,262)   (119,219) (13,950) (143,023)
Proceeds from Issuance of Unsecured Debt (2,257)        
Proceeds from Issuance of Common Stock     49,513   122,584
Proceeds from Convertible Debt       242,701  
Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities 0   (104,165) (185,538) (104,665)
Cash payments on gold production royalty     0   0
Proceeds From Repayment Intercompany Borrowings 9,266   39,297 16,904 26,196
Proceeds from (Payments for) Other Financing Activities (6)   1,051 (3,726) 323
Net Cash Provided by (Used in) Financing Activities 7,003   (14,304) 70,341 44,438
Effect of exchange rate changes on cash and cash equivalents 0   0 0 0
Cash and Cash Equivalents, Period Increase (Decrease) (7,941)   (31,942) 37,889 (262)
Cash and cash equivalents at beginning of period 103,878 58,048 127,803 58,048 96,123
Cash and cash equivalents at end of period 95,937   95,861 95,937 95,861
Guarantor Subsidiaries          
Condensed Financial Statements, Captions [Line Items]          
Net Cash Provided by (Used in) Operating Activities 27,407   48,791 59,434 101,368
Capital expenditures (23,016)   (12,550) (63,928) (38,272)
Payments to Acquire Businesses, Net of Cash Acquired     0   0
Proceeds from the sale of assets 76   560 6,670 4,601
Purchase of short term investments and equity securities (1)   (16) (1) (16)
Sales and maturities of short-term investments 403   5,430 2,164 6,576
Payments for (Proceeds from) Other Investing Activities 0   (7) 0 294
Payments to Acquire Interest in Subsidiaries and Affiliates 7,144   1,356 7,897 25,516
CASH USED IN INVESTING ACTIVITIES (15,394)   (5,227) (47,198) (1,301)
Proceeds from Issuance of Unsecured Debt 0        
Proceeds from Issuance of Common Stock     0   0
Proceeds from Convertible Debt       0  
Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities (1,894)   (2,498) (5,789) (9,001)
Cash payments on gold production royalty     0   0
Proceeds From Repayment Intercompany Borrowings (12,370)   (42,679) (10,809) (73,364)
Proceeds from (Payments for) Other Financing Activities 0   0 0 0
Net Cash Provided by (Used in) Financing Activities (14,264)   (45,177) (16,598) (82,365)
Effect of exchange rate changes on cash and cash equivalents 3   0 3 5
Cash and Cash Equivalents, Period Increase (Decrease) (2,248)   (1,613) (4,359) 17,707
Cash and cash equivalents at beginning of period 47,912 50,023 53,548 50,023 34,228
Cash and cash equivalents at end of period 45,664   51,935 45,664 51,935
Non-Guarantor Subsidiaries          
Condensed Financial Statements, Captions [Line Items]          
Net Cash Provided by (Used in) Operating Activities 9,471   21,586 93,411 53,180
Capital expenditures (6,127)   (13,015) (25,368) (32,619)
Payments to Acquire Businesses, Net of Cash Acquired     (1,427)   (1,427)
Proceeds from the sale of assets 1,007   4,240 951 11,501
Purchase of short term investments and equity securities 0   0 0 0
Sales and maturities of short-term investments 0   0 0 0
Payments for (Proceeds from) Other Investing Activities (67)   (47) (188) (129)
Payments to Acquire Interest in Subsidiaries and Affiliates (1,311)   0 (1,004) 0
CASH USED IN INVESTING ACTIVITIES (6,498)   (10,249) (25,609) (22,674)
Proceeds from Issuance of Unsecured Debt 0        
Proceeds from Issuance of Common Stock     0   0
Proceeds from Convertible Debt       0  
Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities (1,450)   (1,205) (4,174) (6,885)
Cash payments on gold production royalty     (7,563)   (27,155)
Proceeds From Repayment Intercompany Borrowings (4,926)   (4,209) (23,778) 7,992
Proceeds from (Payments for) Other Financing Activities 0   0 0 0
Net Cash Provided by (Used in) Financing Activities (6,376)   (12,977) (27,952) (26,048)
Effect of exchange rate changes on cash and cash equivalents (225)   121 659 (100)
Cash and Cash Equivalents, Period Increase (Decrease) (3,628)   (1,519) 40,509 4,358
Cash and cash equivalents at beginning of period 98,248 54,111 76,240 54,111 70,363
Cash and cash equivalents at end of period 94,620   74,721 94,620 74,721
Eliminations          
Condensed Financial Statements, Captions [Line Items]          
Net Cash Provided by (Used in) Operating Activities 1,236   (124,146) (20,361) (152,503)
Capital expenditures 0   0 0 0
Payments to Acquire Businesses, Net of Cash Acquired     0   0
Proceeds from the sale of assets 0   0 0 0
Purchase of short term investments and equity securities 0   0 0 0
Sales and maturities of short-term investments 0   0 0 0
Payments for (Proceeds from) Other Investing Activities 0   0 0 0
Payments to Acquire Interest in Subsidiaries and Affiliates (9,266)   116,555 2,678 113,327
CASH USED IN INVESTING ACTIVITIES (9,266)   116,555 2,678 113,327
Proceeds from Issuance of Unsecured Debt 0        
Proceeds from Issuance of Common Stock     0   0
Proceeds from Convertible Debt       0  
Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities 0   0 0 0
Cash payments on gold production royalty     0   0
Proceeds From Repayment Intercompany Borrowings 8,030   7,591 17,683 39,176
Proceeds from (Payments for) Other Financing Activities 0   0 0 0
Net Cash Provided by (Used in) Financing Activities 8,030   7,591 17,683 39,176
Effect of exchange rate changes on cash and cash equivalents 0   0 0 0
Cash and Cash Equivalents, Period Increase (Decrease) 0   0 0 0
Cash and cash equivalents at beginning of period 0 $ 0 0 0 0
Cash and cash equivalents at end of period $ 0   $ 0 $ 0 $ 0